See more : ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST) Income Statement Analysis – Financial Results
Complete financial analysis of Atomo Diagnostics Limited (AT1.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Atomo Diagnostics Limited, a leading company in the Medical – Devices industry within the Healthcare sector.
- PS International Group Ltd. (PSIG) Income Statement Analysis – Financial Results
- Henan Pinggao Electric Co.,Ltd. (600312.SS) Income Statement Analysis – Financial Results
- Eastfield Resources Ltd. (ETFLF) Income Statement Analysis – Financial Results
- Oceanwide Holdings Co., Ltd. (000046.SZ) Income Statement Analysis – Financial Results
- Wenzhou Yihua Connector Co., Ltd. (002897.SZ) Income Statement Analysis – Financial Results
Atomo Diagnostics Limited (AT1.AX)
About Atomo Diagnostics Limited
Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. It offers rapid diagnostic test devices for COVID-19, HIV screening, pregnancy test, and respiratory test. The company was incorporated in 2010 and is headquartered in Leichhardt, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.09M | 2.54M | 12.34M | 6.72M | 5.37M | 539.74K | 287.25K | 294.93K |
| Cost of Revenue | 2.65M | 8.62M | 14.19M | 8.43M | 5.83M | 3.11M | 2.35M | 2.60M |
| Gross Profit | 1.44M | -6.08M | -1.85M | -1.71M | -464.83K | -2.57M | -2.06M | -2.31M |
| Gross Profit Ratio | 35.16% | -238.93% | -15.03% | -25.50% | -8.66% | -475.90% | -716.88% | -782.04% |
| Research & Development | 236.42K | 604.72K | 1.41M | 820.64K | 695.01K | 1.34M | 2.88M | 3.21M |
| General & Administrative | 4.06M | 1.02M | 2.59M | 2.00M | 1.08M | 829.27K | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 2.34M | 2.25M | 1.64M | 1.35M | 773.36K | 0.00 | 0.00 |
| SG&A | 4.06M | 3.36M | 4.84M | 3.64M | 2.42M | 1.60M | 1.66M | 1.98M |
| Other Expenses | -2.69M | 1.19M | 2.77M | 405.54K | 3.69M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.61M | 3.96M | 6.25M | 4.46M | 3.12M | 2.94M | 4.54M | 5.18M |
| Cost & Expenses | 8.45M | 12.58M | 20.44M | 12.89M | 8.95M | 6.05M | 6.88M | 7.79M |
| Interest Income | 152.08K | 74.11K | 5.46K | 90.70K | 21.86K | 22.33K | 3.89K | 255.76K |
| Interest Expense | 9.52K | 14.99K | 15.47K | 7.79K | 5.29M | 436.94K | 1.10M | 1.63M |
| Depreciation & Amortization | 1.66M | 1.89M | 2.00M | 1.32M | 687.09K | 560.61K | 329.25K | 243.98K |
| EBITDA | -5.42M | -9.25M | -4.72M | -4.70M | -4.05M | -4.86M | -5.78M | -4.53M |
| EBITDA Ratio | -132.72% | -320.29% | -49.53% | -72.35% | -53.94% | -916.41% | -2,181.14% | -2,457.32% |
| Operating Income | -4.36M | -10.04M | -8.11M | -6.18M | -3.58M | -5.51M | -6.59M | -7.49M |
| Operating Income Ratio | -106.73% | -394.66% | -65.72% | -91.98% | -66.74% | -1,020.27% | -2,295.76% | -2,540.04% |
| Total Other Income/Expenses | -2.49M | -2.97M | -1.49M | -671.77K | -6.44M | -353.87K | -1.09M | 1.34M |
| Income Before Tax | -6.85M | -10.90M | -6.74M | -6.78M | -10.03M | -5.86M | -7.20M | -6.15M |
| Income Before Tax Ratio | -167.57% | -428.67% | -54.60% | -100.90% | -186.73% | -1,085.84% | -2,506.59% | -2,084.45% |
| Income Tax Expense | 0.00 | -946.41K | -1.03M | -754.68K | -807.02K | -805.54K | -2.30M | -999.24K |
| Net Income | -6.85M | -9.96M | -5.71M | -6.02M | -9.22M | -5.06M | -4.90M | -5.15M |
| Net Income Ratio | -167.57% | -391.46% | -46.26% | -89.66% | -171.70% | -936.59% | -1,705.89% | -1,745.65% |
| EPS | -0.01 | -0.02 | -0.01 | -0.01 | -0.03 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.02 | -0.01 | -0.01 | -0.03 | -0.01 | -0.01 | -0.01 |
| Weighted Avg Shares Out | 634.70M | 570.89M | 568.95M | 564.33M | 355.36M | 560.90M | 560.90M | 560.90M |
| Weighted Avg Shares Out (Dil) | 634.66M | 570.89M | 568.95M | 564.33M | 355.36M | 560.90M | 560.90M | 560.90M |
Source: https://incomestatements.info
Category: Stock Reports